Germline FH mutations presenting with pheochromocytoma.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2014-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2014-1659PMID 25004247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Corrigendum: inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

  2015cited by this paper
• Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.

  2014influential reference
• Acrocallosal syndrome: identification of a novel KIF7 mutation and evidence for oligogenic inheritance.

  2013cited by this paper
• SDH mutations establish a hypermethylator phenotype in paraganglioma.

  2013cited by this paper
• Bilateral ovarian steroid cell tumours and massive macronodular adrenocortical disease in a patient with hereditary leiomyomatosis and renal cell cancer syndrome.

  2012influential reference
• Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

  2012cited by this paper
• The genetics of phaeochromocytoma: using clinical features to guide genetic testing.

  2011influential reference
• Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase

  2011cited by this paper
• Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status

  2011cited by this paper
• Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.

  2011cited by this paper
• Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling

  2011cited by this paper
• Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics

  2011cited by this paper
• Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD

  2010influential reference
• UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.

  2010cited by this paper
• Germline SDHB mutations and familial renal cell carcinoma.

  2008influential reference
• Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.

  2005cited by this paper
• A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

  2005cited by this paper
• Phaeochromocytoma.

  2005cited by this paper
• HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

  2005cited by this paper
• Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

  2003cited by this paper
• Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

  2001cited by this paper

• Immunometabolites and cancer: the role of 2-hydroxyglutarate, succinate, fumarate and itaconate in tumour development and anti-tumour immunity.

  2026cites this paper
• Pheochromocytoma and Extra-Adrenal Paragangliomas: An Update in Diagnostics and Clinical Implications.

  2026cites this paper
• Carcinogenesis trajectories

  2025cites this paper
• Epithelial-mesenchymal transition.

  2025cites this paper
• Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature

  2025cites this paper
• Therapeutic Potential of High Dose Vitamin C in Cancer: Mechanisms, Clinical Evidence and Future Directions

  2025cites this paper
• Association between fumarate hydratase variant subtypes and the risk of HLRCC-associated renal cell carcinoma: systematic review and meta-analysis

  2025cites this paper
• Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) and renal cancer

  2025cites this paper
• Succinate dehydrogenase-B fluorescence in situ hybridization in pheochromocytoma-paragangliomas

  2025cites this paper
• Hypoxic Signaling Pathways in Carotid Body Tumors

  2024cites this paper
• Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma

  2024cites this paper
• Hereditary leiomyomatosis and renal cell cancer (HLRCC), pheochromocytoma (PCC)/paraganglioma (PGL) and germline fumarate hydratase (FH) variants

  2024cites this paper
• Update on cancer screening in children with syndromes of bone lesions, hereditary leiomyoma and renal cell carcinoma syndrome, and other rare syndromes.

  2024cites this paper
• Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma

  2024cites this paper
• Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance

  2024cites this paper
• Quadruple Primary Malignancies over 2 Years with Germline Mutation in Krebs Cycle Enzyme Gene Fumarate Hydratase

  2024cites this paper
• Molecular Genetics of Pheochromocytoma/Paraganglioma.

  2024cites this paper
• Genetic changes in the FH gene cause vagal paraganglioma

  2024influential citation
• Familial syndromes associated with testicular and paratesticular neoplasms: a comprehensive review

  2024cites this paper
• A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata

  2023cites this paper
• Hereditary leiomyomatosis and renal cell cancer syndrome

  2023cites this paper
• Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism

  2023cites this paper
• EDITORIAL COMMENT.

  2023cites this paper
• Fumarate Hydratase Variants and their Association with Paraganglioma/Pheochromocytoma.

  2023cites this paper
• Fundamentals of cell metabolism and cancer

  2022cites this paper
• Metabolic determinants of tumour initiation

  2022cites this paper
• A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma

  2022cites this paper
• Fumarate hydratase gene germline variants and mosaicism associated with pheochromocytoma and paraganglioma

  2022cites this paper
• High-Dose Vitamin C for Cancer Therapy

  2022cites this paper
• Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series

  2022cites this paper
• New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications

  2022cites this paper
• Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield

  2022cites this paper
• Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression

  2021cites this paper
• Adrenal Imaging

  2021cites this paper
• Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes

  2021cites this paper
• Simultaneous bilateral laparoscopic cortical-sparing adrenalectomy for bilateral pheochromocytomas in multiple endocrine neoplasia type 2

  2021cites this paper
• Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas

  2021cites this paper
• Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma

  2021cites this paper
• Germline SUCLG2 Variants in Patients with Pheochromocytoma and Paraganglioma.

  2021cites this paper
• Pheochromocytoma

  2021cites this paper
• Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single Center.

  2021cites this paper
• From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy

  2021influential citation
• Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

  2021cites this paper
• Computational Saturation Screen Reveals the Landscape of Mutations in Human Fumarate Hydratase

  2021cites this paper
• Genetics of pheochromocytoma and paraganglioma

  2021cites this paper
• Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism

  2021cites this paper
• Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review

  2021cites this paper
• What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

  2021cites this paper
• Fumarate hydratase in cancer: A multifaceted tumour suppressor.

  2020cites this paper
• Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study

  2020cites this paper
• Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the fumarate hydratase gene

  2020cites this paper
• Paraganglioma of the Organs of Zuckerkandl and FH gene mutation.

  2020cites this paper
• Metabolism and immunity in breast cancer

  2020cites this paper
• Genetic Stratification of Inherited and Sporadic Phaeochromocytoma and Paraganglioma: Implications for Precision Medicine.

  2020cites this paper
• Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors

  2020cites this paper
• Clinical decision making in small non-functioning VHL-related incidentalomas

  2020cites this paper
• The Warburg Effect in Yeast: Repression of Mitochondrial Metabolism Is Not a Prerequisite to Promote Cell Proliferation

  2020cites this paper
• The Significance of Mitochondrial Dysfunction in Cancer

  2020cites this paper
• Pathologic features and clinical course of a non-functioning primary pulmonary paraganglioma: A case report

  2020cites this paper
• Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the fumarate hydratase gene.

  2020cites this paper
• Hereditary Leiomyomatosis and Renal Cell Cancer

  2020cites this paper
• Cardiac myxoma caused by fumarate hydratase gene deletion in patient with cortisol-secreting adrenocortical adenoma.

  2020cites this paper
• EMT Factors and Metabolic Pathways in Cancer

  2020influential citation
• TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition.

  2020cites this paper
• Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

  2020cites this paper
• Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes.

  2020cites this paper
• Metabolic Drivers in Hereditary Cancer Syndromes

  2020cites this paper
• Paragangliomas in Carney–Stratakis Syndrome

  2019cites this paper
• Targeting cancer vulnerabilities with high-dose vitamin C

  2019cites this paper
• Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas.

  2019cites this paper
• The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis

  2019cites this paper
• Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration

  2019cites this paper
• Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches

  2019cites this paper
• Metabolic Plasticity and Epithelial-Mesenchymal Transition

  2019cites this paper
• Genetics of Pheochromocytoma and Paraganglioma

  2019cites this paper
• Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.

  2019cites this paper
• Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin

  2019cites this paper
• Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?

  2019cites this paper
• A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients

  2019cites this paper
• Elucidating the constitutional genetic basis of multiple primary tumours

  2019cites this paper
• Oncometabolites in renal cancer

  2019cites this paper
• Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans

  2019cites this paper
• Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer

  2019cites this paper
• Renal cell carcinoma in young FH mutation carriers: case series and review of the literature

  2019cites this paper
• Editorial: What's New in Endocrinology?

  2019cites this paper
• Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.

  2019cites this paper
• Progress in the diagnosis and treatment of paraganglioma

  2019cites this paper
• The Landscape of Mutations in Fumarate Hydratase

  2019cites this paper
• A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC)

  2018cites this paper
• Metabolism and Transcription in Cancer: Merging Two Classic Tales

  2018cites this paper
• Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma

  2018cites this paper
• Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening

  2018cites this paper
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

  2018cites this paper
• Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma

  2018cites this paper
• [Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes].

  2018cites this paper
• Succinate dehydrogenase (SDH)‐deficient neoplasia

  2018cites this paper
• 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma.

  2018cites this paper
• Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism

  2018influential citation
• The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes

  2018cites this paper
• Biochemical Characterization of Two Clinically-Relevant Human Fumarase Variants Defective for Oligomerization

  2018cites this paper